BaiyaPhytopharm Announces Preliminary Results of the Phase 1 Clinical Trial of its COVID-19 Vaccine Baiya SARS-CoV-2 Vax 2

Baiya SARS-CoV-2 Vax 2, an adjuvant-containing protein vaccine based on antigens produced in plants by BaiyaPharmingTM, is undergoing clinical trials after showing favorable induced response to SARS-CoV-2 in animal models. Preliminary results of the first clinical trial on humans show that the vaccine is safe and that clinical trials should continue. Study Design The ongoing […]